Australia to begin talks on security, defence with EU
By Alasdair Pal and Kirsty Needham
SYDNEY (Reuters) -Australia Prime Minister Anthony Albanese said on Wednesday the country would commence negotiations on a security and defence partnership with the European Union, and was also hopeful of a "symbolically important" trade deal.
Albanese met with the European Commission President Ursula von der Leyen and European Council President Antonio Costa on the sidelines of the G7 summit where they discussed the EU proposal for a defence partnership.
"We see this as an important framework for our current and future cooperation in areas like defence industry, cyber and counter-terrorism," Albanese told a news conference in Kananaskis where he is attending the G7 summit.
Ministers from both sides will progress the talks in the coming weeks, Albanese said, adding he expected discussions to be concluded "pretty quickly".
The EU struck defence partnerships with Japan and South Korea in November.
EU officials have previously said these are not military alliances.
Albanese said he was hopeful that recently revived negotiations for a separate free trade agreement with the European Union would result in a deal.
"At this time its also symbolically important to see an outcome of an expansion of trade, because that is something that is going through difficult times at the moment," he told reporters.
Albanese said "half" of the outstanding issues had been resolved, although Australia wanted to see greater access for its sheep and beef exports to Europe.
Albanese met with senior U.S. trade officials, after the Australian leader's scheduled meeting with President Donald Trump was cancelled when Trump left the G7 a day early.
Australia has highlighted its abundance of critical minerals in negotiations with the United States as it seeks to have U.S. tariffs lifted.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
ESG Executive Briefing 2025: Focus on the US and EU - Tariffs and Policy Shifts Force Companies to Rethink Net-Zero Strategies Amid Rising Compliance and Supply Chain Risks
In 2025, companies face increasing pressure to transparently address environmental, social, and governance (ESG) issues. Holistic ESG strategies can boost trust and sustainability. Challenges include US tariff impacts and EU regulatory changes. This quarterly ESG report offers crucial insights. Dublin, June 18, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: ESG Executive Briefing (First Edition)" report has been added to offering. ESG executive briefing provides quarterly analysis of the ESG trends impacting the corporate world. Sustainability used to be just about saving the planet. Today, it has morphed into an umbrella term for environmental, social, and governance (ESG) a holistic approach that encompasses all environmental, social, and governance issues can help company leaders ensure all aspects of sustainability are covered in their ESG strategy. In 2025, there is pressure on companies to be more transparent about their ESG credentials. The analyst's ESG research is designed to help companies build trust with society at large and set them on a path toward a sustainable Highlights Tariffs have created downside risk for the development and adoption of energy transition technologies in the US. Republicans have also proposed cutting several Biden-era tax credits. US companies must reassess their net-zero targets and roadmaps as electric vehicles, green hydrogen, wind, and solar become less accessible. An EU regulatory rollback and a simplified net-zero standard from the Science Based Targets Initiative (SBTi) mean companies can reduce future compliance costs and focus investment on the highest-emissions parts of their value chains. Companies need to assess the risk to their supply chains from the International Maritime Organization's carbon pricing regime for international shipping. Reasons to Buy This report will help you understand the business impact of environmental, social, and governance (ESG) themes. It includes analysis of the latest developments in ESG standards and regulations and corporate ESG strategies. This edition includes a focus on managing deforestation risk. Key Topics Covered: Executive Summary The Impact of Trump 2.0 on ESG Developments in ESG Regulation and Standards ESG Strategy Focus: How to Manage Deforestation Risk Developments in Corporate ESG Strategies Adopting Your Own ESG Framework Further Reading About the Analyst Strategic Intelligence A selection of companies mentioned in this report includes, but is not limited to: Alaska Airlines Allianz Amazon AstraZeneca Avantor Axa Bank of America Barry Callebaut Ben and Jerry's Blackrock BP Citi Group Corsair DeepSeek Delta Air Lines easyJet Flickr Giliead GSK Haleon IKEA John Deere JPMorgan Chase & Co Labcorp Morgan Stanley Munich Re National Bank of Canada Neste Perrigo Schneider Electric Seneca Group Shell Slalom Steelcase Swiss Re Takeda Tesco Teva ThermoFisher Scientific Unilever United Airlines Vanguard Wells Fargo Zurich For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
28 minutes ago
- Yahoo
Germany Legal Cannabis Market Report 2025-2030: Competitive Analysis of The Cronos Group, Organigram, Tilray, Canopy Growth, Aurora Cannabis, SynBiotic, Cansativa, Four 20 Pharma, and Avextra Pharma
Germany's legal cannabis market, valued at USD 37.15M in 2024, is expected to reach USD 85.64M by 2030, driven by rising acceptance, medical applications, and tech innovations. Key growth factors include government support, increased medical cannabis use, and advanced cultivation technologies. Ideal for market analysis and strategy planning. German Legal Cannabis Market Dublin, June 18, 2025 (GLOBE NEWSWIRE) -- The "Germany Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC, Others), End-use with Growth Forecasts, Key Companies and Competitive Analysis, 2025-2030" report has been added to German Legal Cannabis Market was valued at USD 37.15 million in 2024, and is projected to reach USD 85.64 million by 2030, rising at a CAGR of 14.09%. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany. Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy. In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany's biggest annual gathering of influential political and cannabis business cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast Legal Cannabis Market Report Highlights By source, the hemp segment dominated the market with the highest revenue share of 84.50% in 2024. Hemp covers an extensive range of products, including supplements, nutritional powders, beverages, protein & nutrition bars, animal feed, and pet food. By derivatives, the CBD segment dominated the market with the largest revenue share of 63.61% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health benefits. By end use, the industrial use segment dominated the market with a revenue share of 80.26% in 2024. This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Companies Featured The major companies featured in this Germany Legal Cannabis market report include: The Cronos Group Organigram Holding, Inc Tilray Brands Canopy Growth Corporation Aurora Cannabis SynBiotic Cansativa GmbH DEMECAN Four 20 Pharma Avextra Pharma Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $37.15 Million Forecasted Market Value (USD) by 2030 $85.64 Million Compound Annual Growth Rate 14.0% Regions Covered Germany Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Germany Legal Cannabis Market Variables, Trends, and Scope3.1. Market Lineage Outlook3.2. Germany Legal Cannabis Market - Market Dynamics3.3. Germany Legal Cannabis: Market Analysis Tools3.4. Current Market Trends in Cannabis Industry3.5. Regulatory Scenario3.6. Cannabis Consumption Pattern Analysis3.7. Guidelines and Requirements for Cannabis Cultivation3.8. Cannabis Facility Design and Equipment Requirements3.9. Reimbursement Policies in the GermanyChapter 4. Germany Legal Cannabis Market: Segment Analysis, By Source, 2018-2030 (USD Million)4.1. Definition and Scope4.2. Source Market Share Analysis, 2024 & 20304.3. Segment Dashboard4.4. Germany Legal Cannabis Market, by Source, 2018 to 20304.5. Marijuana4.5.1. Marijuana Market Estimates and Forecasts, 2018-2030 (USD Million)4.5.2. Flower4.5.3. Oil and Tinctures4.6. Hemp4.6.1. Hemp Market Estimates and Forecasts, 2018-2030 (USD Million)4.6.2. Hemp Oil4.6.3. Industrial HempChapter 5. Germany Legal Cannabis Market: Segment Analysis, By Derivative, 2018-2030 (USD Million)5.1. Definition and Scope5.2. Derivative Market Share Analysis, 2024 & 20305.3. Segment Dashboard5.4. Germany Legal Cannabis Market, by Derivative, 2018 to 20305.5. CBD5.6. THC5.7. OthersChapter 6. Germany Legal Cannabis Market: Segment Analysis, By End Use, 2018-2030 (USD Million)6.1. Definition and Scope6.2. End Use Market Share Analysis, 2024 & 20306.3. Segment Dashboard6.4. Germany Legal Cannabis Market, by End Use, 2018 to 20306.5. Medical Use6.5.1. Medical Market Estimates and Forecasts, 2018-2030 (USD Million)6.5.2. Cancer6.5.3. Chronic Pain6.5.4. Depression and Anxiety6.5.5. Arthritis6.5.6. Diabetes6.5.7. Glaucoma6.5.8. Migraines6.5.9. Epilepsy6.5.10. Multiple Sclerosis6.5.11. AIDS6.5.12. Amyotrophic Lateral Sclerosis6.5.13. Alzheimers's6.5.14. Post Traumatic Stress Disorder (PTSD)6.5.15. Parkinson's6.5.16. Tourettes6.5.17. Others6.6. Recreational Use6.7. Industrial UseChapter 7. Germany Legal Cannabis Market: Competitive Landscape7.1. Participant's Categorization7.2. Company Market Position Analysis, 20247.3. Strategy Mapping7.4. Company Profiles The Cronos Group Organigram Holding, Inc Tilray Brands Canopy Growth Corporation Aurora Cannabis SynBiotic Cansativa GmbH DEMECAN Four 20 Pharma Avextra Pharma For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment German Legal Cannabis Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Bloomberg
42 minutes ago
- Bloomberg
Stock Movers: Airbus, Gerresheimer, UBS
On this episode of Stock Movers: - Airbus shares rise as much as 2.3% after the planemaker said it was extending the upper range of its dividend payout ratio to 30-50% from the current level of 30-40%. - Gerresheimer said KPS Capital Partners is still in discussions with Warburg Pincus. Talks on a potential takeover 'are open-ended,' Gerresheimer said - UBS shares fell 1.7%, the worst performer in the Stoxx 600 Financial Services Index, after Morgan Stanley cut its recommendation on the Swiss lender to underweight from equalweight, saying that new capital demands imposed by Switzerland will impact shareholder returns.